Indivior Pharmaceuticals (INDV) Other Non-Current Liabilities (2021 - 2026)
Indivior Pharmaceuticals' Other Non-Current Liabilities came in at $42 million for Q2 2026, down 86.0% from $299 million a year earlier but up 2.4% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, Indivior Pharmaceuticals' Other Non-Current Liabilities was $52 million, down 85.8% from FY2024.
- Other Non-Current Liabilities carries a four-year compound annual growth rate of -42.4% (FY2021 to FY2025).
- Going back by year, Other Non-Current Liabilities was $365 million in FY2024 (+1.7%), $359 million in FY2023 (-16.1%), $428 million in FY2022 (-9.7%) and $474 million in FY2021.
- The five-year range for quarterly Other Non-Current Liabilities is $41 million (Q1 2026) to $474 million (Q4 2021).
- Year-over-year, Other Non-Current Liabilities has declined for three consecutive quarters, with an average decline of 64.1% over the last four quarters.
- Business Quant data shows INDV's Other Non-Current Liabilities at $41 million (Q1 2026), $52 million (Q4 2025) and $300 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Indivior Pharmaceuticals | 4.13 Bn | 3.10 Bn | 294.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.00 Mn |
| Mar 31, 2026 | 62.00 Mn |
| Dec 31, 2025 | 73.00 Mn |
| Sep 30, 2025 | 330.00 Mn |
| Jun 30, 2025 | 317.00 Mn |
| Mar 31, 2025 | 314.00 Mn |
| Dec 31, 2024 | 383.00 Mn |
| Dec 31, 2023 | 390.00 Mn |
| Dec 31, 2022 | 428.00 Mn |
| Dec 31, 2021 | 474.00 Mn |
API Access
Indivior Pharmaceuticals Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();